Skip to main content

Animations

MJFF Publications

6221 - 6230 of 6310 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: A step forward for LRRK2 inhibitors in Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abq7374
    Citation Count: 18
  • Summary Details
    OPEN
    Title: A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson’s Disease Clinical Trial: A Pilot Study
    Journal Name: Digital Biomarkers
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000521232
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma
    Journal Name: Molecular Cancer Therapeutics
    Publisher: American Association for Cancer Research (AACR)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1158/1535-7163.mct-21-0836
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Reliability of Automatic Computer Vision-Based Assessment of Orofacial Kinematics for Telehealth Applications
    Journal Name: Digital Biomarkers
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000525698
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational study
    Journal Name: Multiple Sclerosis Journal
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/13524585221125381
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Association between cigarette smoking and Parkinson’s disease: a neuroimaging study
    Journal Name: Therapeutic Advances in Neurological Disorders
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/17562864221092566
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Height and nigral neuron density in Parkinson’s disease
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-022-02775-2
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort
    Journal Name: Molecular Brain
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13041-022-00964-1
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromes
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-022-00983-z
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-022-01044-1
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.